Abstract:To study mechanisms driving/inhibiting skin carcinogenesis, stage‐specific expression of 14‐3‐3σ (Stratifin) was analyzed in skin carcinogenesis driven by activated rasHa/fos expression (HK1.ras/fos) and ablation of PTEN‐mediated AKT regulation (K14.creP/Δ5PTENflx/flx). Consistent with 14‐3‐3σ roles in epidermal differentiation, HK1.ras hyperplasia and papillomas displayed elevated 14‐3‐3σ expression in supra‐basal keratinocytes, paralleled by supra‐basal p‐MDM2166 activation and sporadic p‐AKT473 expression. In bi‐genic HK1.fos/Δ5PTENflx/flx hyperplasia, basal‐layer 14‐3‐3σ expression appeared, and alongside p53/p21, was associated with keratinocyte differentiation and keratoacanthoma etiology. Tri‐genic HK1.ras/fos‐Δ5PTENflx/flx hyperplasia/papillomas initially displayed increased basal‐layer 14‐3‐3σ, suggesting attempts to maintain supra‐basal p‐MDM2166 and protect basal‐layer p53. However, HK1.ras/fos‐Δ5PTENflx/flx papillomas exhibited increasing basal‐layer p‐MDM2166 activation that reduced p53, which coincided with malignant conversion. Despite p53 loss, 14‐3‐3σ expression persisted in well‐differentiated squamous cell carcinomas (wdSCCs) and alongside elevated p21, limited malignant progression via inhibiting p‐AKT1473 expression; until 14‐3‐3σ/p21 loss facilitated progression to aggressive SCC exhibiting uniform p‐AKT1473. Analysis of TPA‐promoted HK1.ras‐Δ5PTENflx/flx mouse skin, demonstrated early loss of 14‐3‐3σ/p53/p21 in hyperplasia and papillomas, with increased p‐MDM2166/p‐AKT1473 that resulted in rapid malignant conversion and progression to poorly differentiated SCC. In 2D/3D cultures, membranous 14‐3‐3σ expression observed in normal HaCaT and SP1ras61 papilloma keratinocytes was unexpectedly detected in malignant T52ras61/v‐fos SCC cells cultured in monolayers, but not invasive 3D‐cells. Collectively, these data suggest 14‐3‐3σ/Stratifin exerts suppressive roles in papillomatogenesis via MDM2/p53‐dependent mechanisms; while persistent p53‐independent expression in early wdSCC may involve p21‐mediated AKT1 inhibition to limit malignant progression.

Expression of a P53 Mutant in the Epidermis of Transgenic Mice Accelerates Chemical Carcinogenesis

High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene

UV-induced DNA Damage and Mutations in Hupki (human P53 Knock-In) Mice Recapitulate P53 Hotspot Alterations in Sun-Exposed Human Skin.

Genetic Deletion Of P21(Waf1) Enhances Papilloma Formation But Not Malignant Conversion In Experimental Mouse Skin Carcinogenesis

Alterations Of The P53 Tumor-Suppressor Gene In Transformed Mouse-Liver Cells

Dominant-negative but Not Gain-of-function Effects of a P53.r270h Mutation in Mouse Epithelium Tissue after DNA Damage.

Mutant P53r270h Drives Altered Metabolism and Increased Invasion in Pancreatic Ductal Adenocarcinoma.

Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool

P53 Gene Mutations in Skh-1 Mouse Tumors Differentially Induced by Uvb and Combined Subcarcinogenic Benzo[A]Pyrene and Uva

Transgenic Murine Models of Human Cancer: Bridging the Gap from Mouse to Man

Effects of genetic background on tumorigenesis in p53-deficient mice

Expression of a Mutant P53 in Lung Specific Transgenic Mice Cause Age-Related Demographic Shift in Lung Tumor Incidence

The gain of function of p53 cancer mutant in promoting mammary tumorigenesis

Targeted P16(Ink4a) Epimutation Causes Tumorigenesis and Reduces Survival in Mice

Chromosome Stability, in the Absence of Apoptosis, is Critical for Suppression of Tumorigenesis in Trp53 Mutant Mice

Mutagenesis in Vivo in T Cells of P21-Deficient Mice

14‐3‐3σ/Stratifin and p21 limit AKT‐related malignant progression in skin carcinogenesis following MDM2‐associated p53 loss

Blocking Transforming Growth Factor Beta Signaling In Transgenic Epidermis Accelerates Chemical Carcinogenesis: A Mechanism Associated With Increased Angiogenesis

Transgenic human programmed cell death 5 expression in mice suppresses skin cancer development by enhancing apoptosis

p53 mutant mice that display early ageing-associated phenotypes

Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms.